Found 16 matching trials
A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab Versus Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification PHASE3 This study was designed to evaluate the effectiveness and safety of hepatic...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer PHASE2 This is a controlled, open-label, randomized phase- II trial (1:1 randomiza...
Show More Learn More & Join Trial
mFOLFOX7 Plus Camrelizumab and Apatinib in BCLC Stage A/B Hepatocellular Carcinoma Patients Beyond Milan Criteria PHASE2 This study was designed to evaluate the effectiveness and safety of mFOLFOX...
Show More Location
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Learn More & Join Trial
A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification PHASE2 This study was designed to evaluate the effectiveness and safety of hepatic...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer PHASE3 This randomized phase III trial studies how well combination chemotherapy p...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver PHASE2 FC-6 is a Phase II, multi-center clinical trial for patients with unresecta...
Show More Location
Loma Linda University Medical Center
Learn More & Join Trial
Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer PHASE2 This phase II trial studies how well bevacizumab, fluorouracil, leucovorin ...
Show More Location
USC Norris Comprehensive Cancer Center
Learn More & Join Trial
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer PHASE1 This is a phase I trial of CA-4948 in combination with FOLFOX/PD-1 inhibito...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC PHASE3 This is a multi-center randomized phase III clinical study of first-line in...
Show More Location
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Learn More & Join Trial
mFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCC PHASE2 This is a prospective, one-arm, phase II clinical study of intravenous mFOL...
Show More Location
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
Learn More & Join Trial